The FDA’s Advisory Committee’s vote deliberated on Lexicon’s Zynquista (Sotagliflozin) drug, an adjunct to insulin therapy. Shares of Lexicon Pharmaceuticals tanked nearly 33.6% as of 11:30 am ET after the…